Glanbia sales up 10% after starting new joint venture

Glanbia sales increased 9.9% at constant currency in the six months to July 1

Nutrition firm Glanbia reported a 9.9% rise in group revenue, at constant currency, to £1.67bn (€1.85bn), after starting a new joint venture, and selling 60% of its Dairy Ireland business.

Earnings before interest, tax and amortisation were up 6.6%, in the six months to July 1, Glanbia reported today (August 10).

Growth was driven by its Nutritionals business, and its joint venture – Glanbia Ireland – which encompassed Glanbia Ingredients Ireland and Dairy Ireland, said the group’s md Siobhán Talbot.

“The sale of 60% of Dairy Ireland, and related assets, was completed on July 2,” said Talbot. “This business, together with Glanbia Ingredients Ireland, have formed a new joint venture named Glanbia Ireland.

‘Main drivers of growth’

“Glanbia Nutritionals and joint ventures were the main drivers of growth in the first half, and we believe second half earnings progression will also be driven by Glanbia Performance Nutrition where good organic growth is expected for the remainder of the year.”

Glanbia adjusted earnings per share increased 10.1% at constant currency across the six months, to 42p (46.09c). The group’s profit also increased 4.6% to £103.9M (€114.9M).

The Nutritionals business reported a 9% rise in revenue to £580.53M (€642.2M). Growth was driven by a 5.9% price rise, linked to higher dairy markets, Glanbia said.

Glanbia Performance Nutrition was boosted by the firm’s acquisition of Amazing Grass and Body & Fit in February. The business’s revenue increased 5.4% at constant currency to £491.3M (€543.3M).

New innovation centre

The nutrition firm invested £17.3M (€19.1M) across the six months. That included the construction of a new innovation centre in Illinois, US.

Glanbia expected full-year margins to be broadly in line with its first-half, it said. Joint ventures were expected to deliver an improved performance, compared with the previous year, due to improved dairy markets.

Talbot said: “Overall, we reiterate guidance for the full year of pro-forma adjusted earnings per share growth of 7% to 10%, on a constant currency basis.”

Meanwhile, in February, Glanbia reported its seventh consecutive year of double-digit earnings growth.

Glanbia half-year results – at a glance
  • Revenue up 9.9% at constant currency to £1.67bn
  • Earnings before interest, tax and amortisation up 6.6% to £134.1M
  • Pro forma adjusted earnings per share up 13.2% to 42p

Related News

Glanbia and Glanbia Co-op also revealed plans to create Glanbia Ireland

Glanbia revenue increases to €2.85bn

Glanbia has agreed deals for Amazing Grass and Body & Fit

Glanbia buys Amazing Grass and Body & Fit for £156M

Sports brands now have more opportunities to create ‘highly marketable’ drinks

Sports nutrition drinks boosted by lecithin-free option

Vitamin boost: MenaQ7 is claimed to inhibit calcium’s loss in the body

Whey drink offers bone support for over-50s

Weetabix’s £1.4bn sale to Post Holdings leads our gallery of food and drink industry acquisitions

Food and drink acquisitions of the year so far

Battle Oats founders Kevin Smith (left) and Shaun Gibbins (right) secured a deal to supply 300 Holland & Barrett stores

Battle Oats to supply 300 Holland & Barrett stores

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.